Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing, 400016, China.
Cancer Causes Control. 2023 Dec;34(12):1059-1072. doi: 10.1007/s10552-023-01744-5. Epub 2023 Jul 24.
The aim of this study was to identify the heterogeneous and homogeneous prognostic factors associated with distant metastasis to the liver, lung, bone, and brain in colorectal cancer (CRC) patients and then construct nomograms to predict the prognosis.
CRC patients registered in the surveillance, epidemiology, and end results database between 2010 and 2017 were included. A Cox regression model was used to analyse homogeneous and heterogeneous prognostic factors, and Kaplan‒Meier analysis was performed to estimate overall survival (OS). Predictive nomograms were constructed, and their performance was evaluated with C-indexes, calibration curves and the area under the receiver operating characteristic (ROC) curve (AUC).
A total of 37,641 patients with distant metastasis to the liver, lung, bone, and brain were included. The median survival times of patients with liver metastasis, lung metastasis, bone metastasis, and brain metastasis were 12.00 months (95% CI 11.73-12.27 months), 10.00 months (95% CI 9.60-10.41 months), 5.00 months (95% CI 4.52-5.48 months), and 3.00 months (95% CI 2.28-3.72 months), respectively. An older age, higher N stage, elevated carcinoembryonic antigen level, no surgery at the primary site and no/unknown treatment with chemotherapy were identified as homogeneous prognostic factors for the four types of metastases. The calibration curves, C-indexes and AUCs exhibited good performance for predicting the OS of patients with distant metastases to the liver, lung, bone, and brain.
CRC patients with distant metastasis to the liver, lung, bone, and brain exhibited homogeneous and heterogeneous prognostic factors, all of which were associated with shorter survival. The nomograms showed good accuracy and may be used as tools for clinicians to predict the prognosis of CRC patients with distant metastasis.
本研究旨在确定与结直肠癌(CRC)患者肝、肺、骨和脑远处转移相关的异质性和同质性预后因素,并构建列线图以预测预后。
纳入 2010 年至 2017 年登记在监测、流行病学和最终结果数据库中的 CRC 患者。采用 Cox 回归模型分析同质性和异质性预后因素,并进行 Kaplan-Meier 分析以估计总生存期(OS)。构建预测列线图,并通过 C 指数、校准曲线和受试者工作特征(ROC)曲线下面积(AUC)评估其性能。
共纳入 37641 例肝、肺、骨和脑远处转移患者。肝转移、肺转移、骨转移和脑转移患者的中位生存时间分别为 12.00 个月(95%CI 11.73-12.27 个月)、10.00 个月(95%CI 9.60-10.41 个月)、5.00 个月(95%CI 4.52-5.48 个月)和 3.00 个月(95%CI 2.28-3.72 个月)。年龄较大、N 分期较高、癌胚抗原水平升高、原发灶未手术和未/未知化疗是四种转移类型的同质性预后因素。校准曲线、C 指数和 AUC 对预测肝、肺、骨和脑远处转移患者的 OS 具有良好的性能。
CRC 患者发生肝、肺、骨和脑远处转移具有异质性和同质性预后因素,均与生存期缩短相关。该列线图具有良好的准确性,可作为临床医生预测 CRC 远处转移患者预后的工具。